Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information

Completed

Phase N/A Results

Summary of Purpose

In this research study, the investigators are trying to find a better way to set the dose of a common blood-thinning medication. Patients with blood clots or a risk of blood clots (or stroke) sometimes have to take an approved medication called warfarin. Warfarin is a commonly prescribed, approved blood thinning medicine taken by mouth. There is a certain level of warfarin that is best for each patient at...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 July 2013.

1 Jan 2007 16 Nov 2006 1 Jun 2011 1 Jun 2011 1 Jul 2013 20 Mar 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • Regina Silver, RN phone: 617-732-6320 email: rsilver@partners.org or Christine Harker, RN phone: 617-732-6320 email: charker@partners.org

    charker@partners.org